相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeted Interleukin-10 Nanotherapeutics Developed with.a Microfluidic Chip Enhance Resolution of Inflammation in Advanced Atherosclerosis
Nazila Kamaly et al.
ACS NANO (2016)
Liver X receptors at the intersection of lipid metabolism and atherogenesis
Stephen D. Lee et al.
ATHEROSCLEROSIS (2015)
Long-circulating siRNA nanoparticles for validating Prohibitin1-targeted non-small cell lung cancer treatment
Xi Zhu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice
Gabrielle Fredman et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Targeted gold-coated iron oxide nanoparticles for CD163 detection in atherosclerosis by MRI
Carlos Tarin et al.
SCIENTIFIC REPORTS (2015)
Effect of PEG Pairing on the Efficiency of Cancer-Targeting Liposomes
Phei Er Saw et al.
THERANOSTICS (2015)
LXRs link metabolism to inflammation through Abca1-dependent regulation of membrane composition and TLR signaling
Ayaka Ito et al.
ELIFE (2015)
Nanoparticles Containing a Liver X Receptor Agonist Inhibit Inflammation and Atherosclerosis
Xue-Qing Zhang et al.
ADVANCED HEALTHCARE MATERIALS (2015)
Cholesterol, inflammation and innate immunity
Alan R. Tall et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Forming Buried Junctions to Enhance the Photovoltage Generated by Cuprous Oxide in Aqueous Solutions
Pengcheng Dai et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Development of Multinuclear Polymeric Nanoparticles as Robust Protein Nanocarriers
Jun Wu et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Self-assembled hybrid nanoparticles for targeted co-delivery of two drugs into cancer cells
Fujian Huang et al.
CHEMICAL COMMUNICATIONS (2014)
Inflammation and its Resolution as Determinants of Acute Coronary Syndromes
Peter Libby et al.
CIRCULATION RESEARCH (2014)
Interaction of colloidal nanoparticles with their local environment: the (ionic) nanoenvironment around nanoparticles is different from bulk and determines the physico-chemical properties of the nanoparticles
Christian Pfeiffer et al.
JOURNAL OF THE ROYAL SOCIETY INTERFACE (2014)
The scope of nanoparticle therapies for future metastatic melanoma treatment
Francesca Baldelli Bombelli et al.
LANCET ONCOLOGY (2014)
Polymer-lipid hybrid nanoparticles conjugated with anti-EGF receptor antibody for targeted drug delivery to hepatocellular carcinoma
Jie Gao et al.
NANOMEDICINE (2014)
Liver X receptors in lipid metabolism: opportunities for drug discovery
Cynthia Hong et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Imaging and Nanomedicine in Inflammatory Atherosclerosis
Willem J. M. Mulder et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Development of Therapeutic Polymeric Nanoparticles for the Resolution of Inflammation
Suresh Gadde et al.
ADVANCED HEALTHCARE MATERIALS (2014)
Enhanced Cellular Uptake of Peptide-Targeted Nanoparticles through Increased Peptide Hydrophilicity and Optimized Ethylene Glycol Peptide-Linker Length
Jared F. Stefanick et al.
ACS NANO (2013)
A Systematic Analysis of Peptide Linker Length and Liposomal Polyethylene Glycol Coating on Cellular Uptake of Peptide-Targeted Liposomes
Jared F. Stefanick et al.
ACS NANO (2013)
Development and in vivo efficacy of targeted polymeric inflammation-resolving nanoparticles
Nazila Kamaly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
HPMA Copolymers as Surfactants in the Preparation of Biocompatible Nanoparticles for Biomedical Application
Annette Kelsch et al.
BIOMACROMOLECULES (2012)
Binding Affinity and Kinetic Analysis of Targeted Small Molecule-Modified Nanoparticles
Carlos Tassa et al.
BIOCONJUGATE CHEMISTRY (2010)
Spatiotemporal controlled delivery of nanoparticles to injured vasculature
Juliana M. Chan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery
Juliana M. Chan et al.
BIOMATERIALS (2009)
Self-assembled lipid-polymer hybrid nanoparticles: A robust drug delivery platform
Liangfang Zhang et al.
ACS NANO (2008)
Ly-6C(hi) monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata
Filip K. Swirski et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX™/Doxil®) versus conventional doxorubicin for first-line treatment of metastatic breast cancer
MER O'Brien et al.
ANNALS OF ONCOLOGY (2004)
Stimulation of lipogenesis by pharmacological activation of the liver X receptor leads to production of large, triglyceride-rich very low density lipoprotein particles
A Grefhorst et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Synthetic LXR ligand inhibits the development of atherosclerosis in mice
SB Joseph et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors
SB Joseph et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Role of LXRs in control of lipogenesis
JR Schultz et al.
GENES & DEVELOPMENT (2000)
Regulation of mouse sterol regulatory element-binding protein-1c gene (SREBP-1c) by oxysterol receptors, LXRα and LXRβ
JJ Repa et al.
GENES & DEVELOPMENT (2000)
分享论文
